Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion type Assertion NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_head.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion description "[Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_provenance.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion evidence source_evidence_literature NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_provenance.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion SIO_000772 17575153 NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_provenance.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion wasDerivedFrom befree-20140225 NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_provenance.
- NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_assertion wasGeneratedBy ECO_0000203 NP505930.RAggBhB4QJ-b00t6iV_bTifvWjbZt3ymeKeshchlryV0E130_provenance.